Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

¡Esta empresa ha sido trasladada al archivo! Los datos financieros no se han actualizado desde el 27 de febrero de 2015.

Modelo de fijación de precios de activos de capital (CAPM) 

Microsoft Excel

Tasas de retorno

GlaxoSmithKline PLC, tasas mensuales de retorno

Microsoft Excel
GlaxoSmithKline PLC (GSK) Standard & Poor’s 500 (S&P 500)
t Fecha PrecioGSK,t1 DividendoGSK,t1 RGSK,t2 PrecioS&P 500,t RS&P 500,t3
31 ene. 2010 $39.01 1,073.87
1. 28 feb. 2010 $37.14 $0.5737 -3.32% 1,104.49 2.85%
2. 31 mar. 2010 $38.52 3.72% 1,169.43 5.88%
3. 30 abr. 2010 $37.29 -3.19% 1,186.69 1.48%
. . . . . . .
. . . . . . .
. . . . . . .
58. 30 nov. 2014 $46.45 $0.613 3.46% 2,067.56 2.45%
59. 31 dic. 2014 $42.74 -7.99% 2,058.90 -0.42%
Promedio (R): 0.71% 1.18%
Desviación estándar: 4.66% 3.73%
GlaxoSmithKline PLC (GSK) Standard & Poor’s 500 (S&P 500)
t Fecha PrecioGSK,t1 DividendoGSK,t1 RGSK,t2 PrecioS&P 500,t RS&P 500,t3
31 ene. 2010 $39.01 1,073.87
1. 28 feb. 2010 $37.14 $0.5737 -3.32% 1,104.49 2.85%
2. 31 mar. 2010 $38.52 3.72% 1,169.43 5.88%
3. 30 abr. 2010 $37.29 -3.19% 1,186.69 1.48%
4. 31 may. 2010 $33.46 $0.4603 -9.04% 1,089.41 -8.20%
5. 30 jun. 2010 $34.01 1.64% 1,030.71 -5.39%
6. 31 jul. 2010 $35.17 $0.4573 4.76% 1,101.60 6.88%
7. 31 ago. 2010 $37.40 6.34% 1,049.33 -4.74%
8. 30 sept. 2010 $39.52 5.67% 1,141.20 8.76%
9. 31 oct. 2010 $39.04 $0.5074 0.07% 1,183.26 3.69%
10. 30 nov. 2010 $38.28 -1.95% 1,180.55 -0.23%
11. 31 dic. 2010 $39.22 2.46% 1,257.64 6.53%
12. 31 ene. 2011 $36.33 -7.37% 1,286.12 2.26%
13. 28 feb. 2011 $38.61 $0.6153 7.97% 1,327.22 3.20%
14. 31 mar. 2011 $38.41 -0.52% 1,325.83 -0.10%
15. 30 abr. 2011 $43.66 13.67% 1,363.61 2.85%
16. 31 may. 2011 $43.46 $0.5263 0.75% 1,345.20 -1.35%
17. 30 jun. 2011 $42.90 -1.29% 1,320.64 -1.83%
18. 31 jul. 2011 $44.42 3.54% 1,292.28 -2.15%
19. 31 ago. 2011 $42.83 $0.5211 -2.41% 1,218.89 -5.68%
20. 30 sept. 2011 $41.29 -3.60% 1,131.42 -7.18%
21. 31 oct. 2011 $44.79 8.48% 1,253.30 10.77%
22. 30 nov. 2011 $44.48 $0.543 0.52% 1,246.96 -0.51%
23. 31 dic. 2011 $45.63 2.59% 1,257.60 0.85%
24. 31 ene. 2012 $44.54 -2.39% 1,312.41 4.36%
25. 29 feb. 2012 $44.31 $0.8213 1.33% 1,365.68 4.06%
26. 31 mar. 2012 $44.91 1.35% 1,408.47 3.13%
27. 30 abr. 2012 $46.23 2.94% 1,397.91 -0.75%
28. 31 may. 2012 $44.11 $0.5491 -3.40% 1,310.33 -6.27%
29. 30 jun. 2012 $45.57 3.31% 1,362.16 3.96%
30. 31 jul. 2012 $46.00 0.94% 1,379.32 1.26%
31. 31 ago. 2012 $45.49 $0.5279 0.04% 1,406.58 1.98%
32. 30 sept. 2012 $46.24 1.65% 1,440.67 2.42%
33. 31 oct. 2012 $44.90 -2.90% 1,412.16 -1.98%
34. 30 nov. 2012 $43.01 $0.579 -2.92% 1,416.18 0.28%
35. 31 dic. 2012 $43.47 1.07% 1,426.19 0.71%
36. 31 ene. 2013 $45.61 4.92% 1,498.11 5.04%
37. 28 feb. 2013 $44.03 $0.6895 -1.95% 1,514.68 1.11%
38. 31 mar. 2013 $46.91 6.54% 1,569.19 3.60%
39. 30 abr. 2013 $51.64 10.08% 1,597.57 1.81%
40. 31 may. 2013 $51.77 $0.5502 1.32% 1,630.74 2.08%
41. 30 jun. 2013 $49.97 -3.48% 1,606.28 -1.50%
42. 31 jul. 2013 $50.96 1.98% 1,685.73 4.95%
43. 31 ago. 2013 $50.89 $0.5532 0.95% 1,632.97 -3.13%
44. 30 sept. 2013 $50.17 -1.41% 1,681.55 2.97%
45. 31 oct. 2013 $52.63 4.90% 1,756.54 4.46%
46. 30 nov. 2013 $52.92 $0.6161 1.72% 1,805.81 2.80%
47. 31 dic. 2013 $53.39 0.89% 1,848.36 2.36%
48. 31 ene. 2014 $51.54 -3.47% 1,782.59 -3.56%
49. 28 feb. 2014 $55.94 $0.7496 9.99% 1,859.45 4.31%
50. 31 mar. 2014 $53.43 -4.49% 1,872.34 0.69%
51. 30 abr. 2014 $55.37 3.63% 1,883.95 0.62%
52. 31 may. 2014 $53.94 $0.64 -1.43% 1,923.57 2.10%
53. 30 jun. 2014 $53.48 -0.85% 1,960.23 1.91%
54. 31 jul. 2014 $48.37 -9.55% 1,930.67 -1.51%
55. 31 ago. 2014 $49.10 $0.6482 2.85% 2,003.37 3.77%
56. 30 sept. 2014 $45.97 -6.37% 1,972.29 -1.55%
57. 31 oct. 2014 $45.49 -1.04% 2,018.05 2.32%
58. 30 nov. 2014 $46.45 $0.613 3.46% 2,067.56 2.45%
59. 31 dic. 2014 $42.74 -7.99% 2,058.90 -0.42%
Promedio (R): 0.71% 1.18%
Desviación estándar: 4.66% 3.73%

Mostrar todo

1 Datos en dólares estadounidenses por acción ordinaria, ajustados por divisiones y dividendos de acciones.

2 Tasa de rendimiento de las acciones ordinarias de GSK durante el período t.

3 Tasa de rendimiento del S&P 500 (el proxy de la cartera de mercado) durante el período t.


Varianza y covarianza

GlaxoSmithKline PLC, cálculo de la varianza y covarianza de los rendimientos

Microsoft Excel
t Fecha RGSK,t RS&P 500,t (RGSK,tRGSK)2 (RS&P 500,tRS&P 500)2 (RGSK,tRGSK)×(RS&P 500,tRS&P 500)
1. 28 feb. 2010 -3.32% 2.85% 16.24 2.80 -6.74
2. 31 mar. 2010 3.72% 5.88% 9.05 22.11 14.15
3. 30 abr. 2010 -3.19% 1.48% 15.21 0.09 -1.16
. . . . . . .
. . . . . . .
. . . . . . .
58. 30 nov. 2014 3.46% 2.45% 7.57 1.63 3.51
59. 31 dic. 2014 -7.99% -0.42% 75.59 2.55 13.88
Total (Σ): 1,259.77 809.11 507.46
t Fecha RGSK,t RS&P 500,t (RGSK,tRGSK)2 (RS&P 500,tRS&P 500)2 (RGSK,tRGSK)×(RS&P 500,tRS&P 500)
1. 28 feb. 2010 -3.32% 2.85% 16.24 2.80 -6.74
2. 31 mar. 2010 3.72% 5.88% 9.05 22.11 14.15
3. 30 abr. 2010 -3.19% 1.48% 15.21 0.09 -1.16
4. 31 may. 2010 -9.04% -8.20% 94.93 87.90 91.35
5. 30 jun. 2010 1.64% -5.39% 0.88 43.11 -6.15
6. 31 jul. 2010 4.76% 6.88% 16.39 32.49 23.08
7. 31 ago. 2010 6.34% -4.74% 31.74 35.08 -33.37
8. 30 sept. 2010 5.67% 8.76% 24.62 57.42 37.60
9. 31 oct. 2010 0.07% 3.69% 0.41 6.29 -1.60
10. 30 nov. 2010 -1.95% -0.23% 7.04 1.98 3.73
11. 31 dic. 2010 2.46% 6.53% 3.06 28.65 9.36
12. 31 ene. 2011 -7.37% 2.26% 65.22 1.18 -8.78
13. 28 feb. 2011 7.97% 3.20% 52.74 4.07 14.66
14. 31 mar. 2011 -0.52% -0.10% 1.50 1.64 1.57
15. 30 abr. 2011 13.67% 2.85% 168.00 2.79 21.67
16. 31 may. 2011 0.75% -1.35% 0.00 6.39 -0.10
17. 30 jun. 2011 -1.29% -1.83% 3.98 9.02 5.99
18. 31 jul. 2011 3.54% -2.15% 8.04 11.06 -9.43
19. 31 ago. 2011 -2.41% -5.68% 9.69 47.02 21.35
20. 30 sept. 2011 -3.60% -7.18% 18.51 69.79 35.94
21. 31 oct. 2011 8.48% 10.77% 60.37 92.06 74.55
22. 30 nov. 2011 0.52% -0.51% 0.03 2.83 0.31
23. 31 dic. 2011 2.59% 0.85% 3.53 0.11 -0.61
24. 31 ene. 2012 -2.39% 4.36% 9.58 10.12 -9.85
25. 29 feb. 2012 1.33% 4.06% 0.39 8.30 1.79
26. 31 mar. 2012 1.35% 3.13% 0.42 3.82 1.27
27. 30 abr. 2012 2.94% -0.75% 4.98 3.72 -4.30
28. 31 may. 2012 -3.40% -6.27% 16.85 55.40 30.55
29. 30 jun. 2012 3.31% 3.96% 6.78 7.72 7.23
30. 31 jul. 2012 0.94% 1.26% 0.06 0.01 0.02
31. 31 ago. 2012 0.04% 1.98% 0.45 0.64 -0.53
32. 30 sept. 2012 1.65% 2.42% 0.89 1.55 1.17
33. 31 oct. 2012 -2.90% -1.98% 13.00 9.96 11.38
34. 30 nov. 2012 -2.92% 0.28% 13.15 0.80 3.24
35. 31 dic. 2012 1.07% 0.71% 0.13 0.22 -0.17
36. 31 ene. 2013 4.92% 5.04% 17.77 14.94 16.30
37. 28 feb. 2013 -1.95% 1.11% 7.07 0.01 0.19
38. 31 mar. 2013 6.54% 3.60% 34.04 5.86 14.12
39. 30 abr. 2013 10.08% 1.81% 87.91 0.40 5.91
40. 31 may. 2013 1.32% 2.08% 0.37 0.81 0.55
41. 30 jun. 2013 -3.48% -1.50% 17.50 7.17 11.20
42. 31 jul. 2013 1.98% 4.95% 1.62 14.20 4.80
43. 31 ago. 2013 0.95% -3.13% 0.06 18.55 -1.04
44. 30 sept. 2013 -1.41% 2.97% 4.50 3.23 -3.81
45. 31 oct. 2013 4.90% 4.46% 17.61 10.77 13.77
46. 30 nov. 2013 1.72% 2.80% 1.03 2.65 1.65
47. 31 dic. 2013 0.89% 2.36% 0.03 1.39 0.21
48. 31 ene. 2014 -3.47% -3.56% 17.41 22.43 19.76
49. 28 feb. 2014 9.99% 4.31% 86.20 9.82 29.10
50. 31 mar. 2014 -4.49% 0.69% 26.98 0.23 2.52
51. 30 abr. 2014 3.63% 0.62% 8.55 0.31 -1.63
52. 31 may. 2014 -1.43% 2.10% 4.55 0.86 -1.97
53. 30 jun. 2014 -0.85% 1.91% 2.43 0.53 -1.14
54. 31 jul. 2014 -9.55% -1.51% 105.31 7.21 27.56
55. 31 ago. 2014 2.85% 3.77% 4.59 6.70 5.54
56. 30 sept. 2014 -6.37% -1.55% 50.15 7.45 19.33
57. 31 oct. 2014 -1.04% 2.32% 3.07 1.31 -2.00
58. 30 nov. 2014 3.46% 2.45% 7.57 1.63 3.51
59. 31 dic. 2014 -7.99% -0.42% 75.59 2.55 13.88
Total (Σ): 1,259.77 809.11 507.46

Mostrar todo

VarianzaGSK = Σ(RGSK,tRGSK)2 ÷ (59 – 1)
= 1,259.77 ÷ (59 – 1)
= 21.72

VarianzaS&P 500 = Σ(RS&P 500,tRS&P 500)2 ÷ (59 – 1)
= 809.11 ÷ (59 – 1)
= 13.95

CovarianzaGSK, S&P 500 = Σ(RGSK,tRGSK)×(RS&P 500,tRS&P 500) ÷ (59 – 1)
= 507.46 ÷ (59 – 1)
= 8.75


Estimación sistemática del riesgo (β)

Microsoft Excel
VarianzaGSK 21.72
VarianzaS&P 500 13.95
CovarianzaGSK, S&P 500 8.75
Coeficiente de correlaciónGSK, S&P 5001 0.50
βGSK2 0.63
αGSK3 -0.03%

Cálculos

1 Coeficiente de correlaciónGSK, S&P 500
= CovarianzaGSK, S&P 500 ÷ (Desviación estándarGSK × Desviación estándarS&P 500)
= 8.75 ÷ (4.66% × 3.73%)
= 0.50

2 βGSK
= CovarianzaGSK, S&P 500 ÷ VarianzaS&P 500
= 8.75 ÷ 13.95
= 0.63

3 αGSK
= PromedioGSK – βGSK × PromedioS&P 500
= 0.71%0.63 × 1.18%
= -0.03%


Tasa de rendimiento esperada

Microsoft Excel
Suposiciones
Tasa de rendimiento del LT Treasury Composite1 RF 4.86%
Tasa de rendimiento esperada de la cartera de mercado2 E(RM) 13.52%
Riesgo sistemático de GlaxoSmithKline acciones ordinarias βGSK 0.63
 
Tasa de rendimiento esperada de las acciones ordinarias de GlaxoSmithKline3 E(RGSK) 10.29%

1 Promedio no ponderado de los rendimientos de las ofertas de todos los bonos del Tesoro de EE. UU. con cupón fijo en circulación que no vencen ni son rescatables en menos de 10 años (proxy de tasa de rendimiento libre de riesgo).

2 Ver detalles »

3 E(RGSK) = RF + βGSK [E(RM) – RF]
= 4.86% + 0.63 [13.52%4.86%]
= 10.29%